These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 9495299)
1. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Schumacher B; Pecher P; von Specht BU; Stegmann T Circulation; 1998 Feb; 97(7):645-50. PubMed ID: 9495299 [TBL] [Abstract][Full Text] [Related]
2. The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: first clinical results. Schumacher B; Stegmann T; Pecher P J Cardiovasc Surg (Torino); 1998 Dec; 39(6):783-9. PubMed ID: 9972900 [TBL] [Abstract][Full Text] [Related]
3. Angiogenic therapy of the human heart. Folkman J Circulation; 1998 Feb; 97(7):628-9. PubMed ID: 9495294 [No Abstract] [Full Text] [Related]
4. [Neoangiogenesis by local gene therapy: a new therapeutic concept in the treatment of coronary disease]. Schumacher B; Hannekum A; Pecher P Z Kardiol; 2000; 89 Suppl 7():23-30. PubMed ID: 11098556 [TBL] [Abstract][Full Text] [Related]
5. The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts. Lutter G; Attmann T; Heilmann C; von Samson P; von Specht B; Beyersdorf F Eur J Cardiothorac Surg; 2002 Nov; 22(5):753-61. PubMed ID: 12414042 [TBL] [Abstract][Full Text] [Related]
6. Comparison of protein with DNA therapy for chronic myocardial ischemia using fibroblast growth factor-2. Heilmann C; von Samson P; Schlegel K; Attmann T; von Specht BU; Beyersdorf F; Lutter G Eur J Cardiothorac Surg; 2002 Dec; 22(6):957-64. PubMed ID: 12467820 [TBL] [Abstract][Full Text] [Related]
7. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. Laham RJ; Rezaee M; Post M; Novicki D; Sellke FW; Pearlman JD; Simons M; Hung D J Pharmacol Exp Ther; 2000 Feb; 292(2):795-802. PubMed ID: 10640320 [TBL] [Abstract][Full Text] [Related]
8. Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial. Harskamp RE; Alexander JH; Ferguson TB; Hager R; Mack MJ; Englum B; Wojdyla D; Schulte PJ; Kouchoukos NT; de Winter RJ; Gibson CM; Peterson ED; Harrington RA; Smith PK; Lopes RD Circulation; 2016 Jan; 133(2):131-8. PubMed ID: 26647082 [TBL] [Abstract][Full Text] [Related]
9. [Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic approach in coronary heart disease]. Stegmann TJ; Hoppert T; Schneider A; Gemeinhardt S; Köcher M; Ibing R; Strupp G Herz; 2000 Sep; 25(6):589-99. PubMed ID: 11076317 [TBL] [Abstract][Full Text] [Related]
12. Effects of in vivo gene transfer of fibroblast growth factor-2 on cardiac function and collateral vessel formation in the microembolized rabbit heart. Iwatate M; Miura T; Ikeda Y; Kawamura S; Dairaku Y; Okamura T; Kimura M; Yamaguchi K; Ueno H; Matsuzaki M Jpn Circ J; 2001 Mar; 65(3):226-31. PubMed ID: 11266199 [TBL] [Abstract][Full Text] [Related]
13. The stimulation of neo-angiogenesis in the ischemic heart by the human growth factor FGF. Schumacher B; von Specht BU; Haberstroh J; Pecher P J Cardiovasc Surg (Torino); 1998 Aug; 39(4):445-53. PubMed ID: 9788790 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Sellke FW; Laham RJ; Edelman ER; Pearlman JD; Simons M Ann Thorac Surg; 1998 Jun; 65(6):1540-4. PubMed ID: 9647055 [TBL] [Abstract][Full Text] [Related]
15. Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart. Watanabe E; Smith DM; Sun J; Smart FW; Delcarpio JB; Roberts TB; Van Meter CH; Claycomb WC Basic Res Cardiol; 1998 Feb; 93(1):30-7. PubMed ID: 9538935 [TBL] [Abstract][Full Text] [Related]
16. [Neoangiogenesis by local gene therapy: a new therapeutic approach in the treatment of coronary artery disease]. Schumacher B; Hannekum A; Pecher P Z Kardiol; 2000 Oct; 89(Suppl 7):23-30. PubMed ID: 27320522 [TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Unger EF; Banai S; Shou M; Lazarous DF; Jaklitsch MT; Scheinowitz M; Correa R; Klingbeil C; Epstein SE Am J Physiol; 1994 Apr; 266(4 Pt 2):H1588-95. PubMed ID: 8184938 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia. Horio T; Fujita M; Tanaka Y; Ishihara M; Kishimoto S; Nakamura S; Hase K; Maehara T J Vasc Surg; 2011 Sep; 54(3):791-8. PubMed ID: 21620612 [TBL] [Abstract][Full Text] [Related]
20. Creation of anastomoses between an extracardiac artery and the coronary circulation. Proof that myocardial angiogenesis occurs and can provide nutritional blood flow to the myocardium. Unger EF; Sheffield CD; Epstein SE Circulation; 1990 Oct; 82(4):1449-66. PubMed ID: 1698130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]